Cited 0 times in
Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, JY | - |
dc.contributor.author | Lee, YS | - |
dc.contributor.author | Kim, SS | - |
dc.contributor.author | Song, DS | - |
dc.contributor.author | Lee, JH | - |
dc.contributor.author | Kim, JH | - |
dc.date.accessioned | 2023-01-26T06:10:36Z | - |
dc.date.available | 2023-01-26T06:10:36Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/24162 | - |
dc.language.iso | en | - |
dc.subject.MESH | COVID-19 | - |
dc.subject.MESH | Disease Management | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms | - |
dc.subject.MESH | Pandemics | - |
dc.subject.MESH | SARS-CoV-2 | - |
dc.title | Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline | - |
dc.type | Article | - |
dc.identifier.pmid | 34530524 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524065/ | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | Hepatitis | - |
dc.subject.keyword | Hepatocellular carcinoma | - |
dc.subject.keyword | Liver cirrhosis | - |
dc.subject.keyword | SARS-CoV-2 | - |
dc.contributor.affiliatedAuthor | Kim, SS | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.3350/CMH.2021.0293 | - |
dc.citation.title | Clinical and molecular hepatology | - |
dc.citation.volume | 27 | - |
dc.citation.number | 4 | - |
dc.citation.date | 2021 | - |
dc.citation.startPage | 515 | - |
dc.citation.endPage | 523 | - |
dc.identifier.bibliographicCitation | Clinical and molecular hepatology, 27(4). : 515-523, 2021 | - |
dc.identifier.eissn | 2287-285X | - |
dc.relation.journalid | J022872728 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.